Latest Development Pipeline News

Finbar Group has fast-tracked Ronald Chan’s appointment as CEO, aiming to leverage his deep company experience to strengthen its development pipeline and growth strategy.

National Storage REIT has partnered with GIC to invest $228 million in a second tranche of self-storage development assets, reaffirming its FY25 earnings guidance and strategic growth plans.

EVE Health Group has initiated stability testing for its novel oral treatments targeting erectile dysfunction and dysmenorrhea, marking a crucial step toward regulatory approval in Australia. The company also finalizes its acquisition of Nextract, the developer behind these innovative formulations.

Nordic Resources has validated a significant new indicated gold resource at the Kiimala Trend in Finland, lifting its total gold equivalent inventory close to 1 million ounces. This milestone follows the pending acquisition of three Finnish gold projects from Northgold AB.

Goodman Group reports steady progress in Q3 FY25 with a robust $13.7 billion development pipeline and strong demand for logistics and data centre infrastructure, reaffirming its FY25 Operating EPS growth forecast of 9%.

Infratil Limited reported a robust FY2025 with operational EBITDAF nearing NZ$1 billion, driven by strong performances across its core infrastructure sectors and a strategic capital raise to fuel CDC Data Centres’ expansion.

WIN Metals has unveiled an Exploration Target at its Golden Crown gold deposit, aiming to add up to 73,000 ounces of gold beyond existing resources. A 9,000-metre drilling program is set to commence in July 2025 to test this promising extension.

Mustera Property Group has promoted long-serving Executive Director Nicholas Zborowski to Managing Director, signaling continuity in leadership as the company advances key development projects.

Oceania Healthcare Limited reported a robust FY25 with a 9.2% rise in sales volume and a 5.8% increase in comprehensive income, underpinned by a successful $500 million debt refinancing and operational enhancements.

Minerals 260 has agreed to sell its Aston Lithium-REE Project to Delta Lithium for $450,000 cash plus a 1.5% royalty, redirecting its efforts toward advancing the 2.3 million ounce Bullabulling Gold Project in Western Australia.

Noxopharm Limited has raised nearly $2.5 million by selling its entire stake in Nyrada Inc, providing non-dilutive capital to advance its HERACLES clinical trial and expand its research pipeline.

Astute Metals has reported its highest-grade lithium intercept to date at the Red Mountain Project in Nevada, extending mineralisation over a 5.6-kilometre strike length and reinforcing the project's growing significance in the US lithium landscape.